Yard Force Introduces the 21W Portable Solar Charger with Dual USB Ports and 13000 mAh Built-in Battery
Yard Force is excited to announce the launch of the 21W Portable Solar Charger, a revolutionary device designed to provide reliable and efficient power for all your USB devices, whether you are indoors or outdoors. This innovative product combines the functionality of a powerful 13000 mAh power bank with high-efficiency solar panels, offering a seamless and eco-friendly solution for all your charging needs. The Yard Force 21W Portable Solar Charger is now available for purchase on Amazon.de here.
Key Features of the Yard Force 21W Portable Solar Charger:
- Evolutionary Dual Functionality: The Yard Force 21W combines a robust 13000 mAh power bank with efficient solar cells to ensure continuous power supply. Whether indoors or outdoors, you can rely on this device for all your power needs, eliminating the hassle of carrying multiple gadgets.
- Unlimited Solar Energy: Equipped with industry-leading solar cells, this charger converts up to 24% of sunlight into energy, ensuring your power bank is always charged. Experience true freedom from electrical outlets – perfect for any adventure.
- Dual High-Speed USB Charging: Featuring two high-speed USB ports, the LX PB21 can simultaneously charge two devices with a total output of 5V/3A. Enjoy fast and efficient charging for your smartphones, tablets, and more.
- Built for Durability: Designed to withstand the elements, this weather-resistant power bank is perfect for camping, hiking, fishing, and traveling. Trust the LX PB21 to keep you connected in all conditions.
- Customer Satisfaction Guarantee: Join thousands of satisfied customers who have chosen an eco-friendly power solution. Enjoy reliable energy and peace of mind with the Yard Force 21W Portable Solar Charger.
Availability and Purchase:
The Yard Force 21W Portable Solar Charger is available for purchase on Amazon.de. To learn more and place your order, visit Amazon.de.
About Yard Force:
Yard Force is a global leader in innovative garden tools and outdoor power equipment. Known for our dedication to quality, performance, and customer satisfaction, we strive to enhance the outdoor experience with our cutting-edge products. Yard Force is committed to delivering reliable and efficient solutions that meet the diverse needs of our customers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240627568365/en/
Contacts
Media:
Yinlu Lin
carl@yardforce.eu
+86-25-58638031
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses28.6.2024 17:30:00 CEST | Press release
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announces new data from the 4th interim analysis of the PEARL migraine prevention study with AJOVY® (fremanezumab) that may challenge the rationale for treatment pauses with calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) mandated or recommended by some reimbursement authorities after one year of continuous use. The sub-analysis from the PEARL real world data explored the impact of fremanezumab treatment cessation and reinitiation on monthly migraine days (MMD) in adult patients with episodic or chronic migraine. The data1 show that pausing treatment of fremanezumab, a CGRP-pathway mAb, may result in a potential rise in monthly migraine days (MMD) following treatment cessation and reduced effectiveness upon reinitiation compared to the first treatment cycle, adding to the burden of the individual living with migraine: Over 40% of patients experienced a rapid worsening of their migraine (>=50% increase in
AQEMIA Achieves Research Milestone Against Undruggable Target in Immuno-Oncology with Servier28.6.2024 07:30:00 CEST | Press release
AQEMIA, a leading company in generative-AI-driven drug discovery, announces the achievement of a research milestone in its collaboration with Servier, an international independent pharmaceutical company, to address an undruggable target in immuno-oncology. Based on AQEMIA ‘s quantum and statistical physics-based calculations, and within the span of a few months, a series of molecules experimentally active on an undruggable target in immuno-oncology have been successfully identified. This milestone triggers an undisclosed payment to AQEMIA. "Our teams are very proud of this achievement that demonstrates the power of AQEMIA's cutting-edge generative AI and deep physics in creating novel, patentable molecules to meet therapeutic needs that are still immense, particularly in the field of immuno-oncology. Within the framework of our collaboration with Servier, we have reached the stage where a series of molecules are subsequently proven impactful in vitro and in vivo assays. " said Maximili
Yard Force Launches the LX PS300 Portable Power Station - Your Ultimate Mobile Power Solution28.6.2024 06:12:00 CEST | Press release
Yard Force is excited to announce the launch of the LX PS300 Portable Power Station, a versatile and powerful battery backup solution designed for a variety of applications, from camping and outdoor activities to emergency power supply. With a battery capacity of 296Wh and peak output of 600W, the LX PS300 provides reliable and efficient power for all your electronic devices. The Yard Force LX PS300 Portable Power Station is now available for purchase on Amazon.de here. Key Features of the Yard Force LX PS300 Portable Power Station: Mobile Power Supply: The LX PS300 is the ideal portable power station for camping, RV trips, outdoor activities, garden sheds, picnics, festivals, or as an emergency power supply. It offers a battery capacity of 296Wh (600W peak) and is suitable for use with electronic devices such as smartphones, tablets, and more. Fast Recharge Time: Compatible with separately available solar panels (LX SPP10/100W and LX SPP20/200W), the LX PS300 can be fully recharged in
Yard Force Introduces the 100W Portable Solar Panel LX SPP10 - Your Ideal Solar Charging Solution28.6.2024 06:00:00 CEST | Press release
Yard Force is proud to unveil the 100W Portable Solar Panel LX SPP10, a highly efficient and versatile solar charger designed to provide optimal power supply in conjunction with Yard Force Power Stations. Perfect for outdoor activities and emergency power needs, the LX SPP10 ensures reliable and eco-friendly energy wherever you go. The Yard Force 100W Portable Solar Panel is now available for purchase on Amazon.de here. Key Features of the Yard Force 100W Portable Solar Panel LX SPP10: Mobile Power Supply: Specifically designed to maximize performance when paired with Yard Force Power Stations, the 100W solar panel boasts an impressive efficiency rate of 23.5% and 95% transparency for efficient conversion of solar energy into electrical power. Waterproof Design: With its seamless construction, the Yard Force 100W Solar Panel is waterproof, making it perfect for all outdoor activities. Whether camping, hiking, or in an emergency situation, this solar panel ensures a continuous power sup
Brenus Pharma graduates from the Creative Destruction Lab’s 2023/2024 Global Cancer Stream, in partnership with North American Universities.27.6.2024 21:51:00 CEST | Press release
A year ago, Brenus was selected to participate in CDL Cancer, a global mentorship program for massively scalable, science-based and innovative companies accelerating cancer treatment. Thanks to its pioneering STC platform, dedicated to developing a new generation of therapeutic cancer vaccines, Brenus stood out during a scientific evaluation with Dr. John Bell (Principal Senior Scientist at Ottawa Hospital Cancer Research Institute & Professor of Medicine & Immunology at University of Ottawa). Brenus has graduated from the program along with 9 other companies, successfully completing the 4 sessions that took place from October 2023 to June 2024 across North America. In this program, Brenus came to seek strategic, international guidance for the development of its platform and their lead candidate targeting colorectal cancer. During each session, the objectives and updates presented were challenged by the CDL community and mentors: successful entrepreneurs, investors, corporate partners,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom